Author:
Beer Tomasz M.,Goldman Bryan,Nichols Craig R.,Petrylak Daniel P.,Agarwal Manoj,Ryan Christopher W.,Crawford E. David
Reference17 articles.
1. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study [published erratum appears in J Clin Oncol 1993; 11:384];Loehrer;J Clin Oncol,1992
2. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J Clin Oncol,1990
3. Gemcitabine and cisplatin (GC) versus methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy in advanced or metastatic transitional cell carcinoma (TCC) of the urothelium: a large randomized multicenter, multinational phase III study;Von der Maase;Proc Am Soc Clin Oncol,2000
4. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy;Geller;Cancer,1991
5. Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study;Gebbia;Clin Ter,1999
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献